Should children with cerebral palsy and normal imaging undergo testing for inherited metabolic disorders?

Developmental Medicine and Child Neurology

Volumn 53, Issue 3, 2011, Pages 226-232

  Leonard, Jane M ^a   Cozens, Alison L ^b   Reid, Susan M ^c   Fahey, Michael C ^b   Ditchfield, Michael R ^a   Reddihough, Dinah S ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b Genetic Health Services Victoria   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATAXIA; CEREBRAL PALSY; CHILD; CLINICAL ASSESSMENT; DISEASE SEVERITY; DYSKINESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MOTOR PERFORMANCE; MUSCLE HYPOTONIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPASTICITY;

BIOLOGICAL MARKERS; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; GESTATIONAL AGE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC DISEASES; MOTOR SKILLS; NEOPTERIN; PROLACTIN; SEVERITY OF ILLNESS INDEX;

EID: 79551565201     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2010.03810.x     Document Type: Article

References (22)

1. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol 2007; 49(Suppl.): 8-14.
2. Ashwal S, Russman BS, Blasco PA, Miller G, Sandler A, Shevell M. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2004; 62: 851-63.
3. Korzeniewski S, Birbeck G, DeLano M, Potchen M, Paneth N. A systematic review of neuroimaging for cerebral palsy. J Child Neurol 2008; 23: 216-27.
4. Krägeloh-Mann I, Horber V. The role of magnetic resonance imaging in elucidating the pathogenesis of cerebral palsy: a systematic review. Dev Med Child Neurol 2007; 49: 144-51.
5. Bax M, Tydeman C, Flodmark O. Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study. JAMA 2006; 296: 1602-8.
6. Robinson MN, Peake LJ, Ditchfield MR, Reid SM, Lanigan A, Reddihough DS. Magnetic resonance imaging findings in a population-based cohort of children with cerebral palsy. Dev Med Child Neurol 2008; 51: 39-45.
7. Yin R, Reddihough DS, Ditchfield MR, Collins KJ. Magnetic resonance imaging findings in cerebral palsy. J Paediatr Child Health 2000; 36: 139-44.
8. Garcia-Cazorla A, Wolf NI, Serrano M, et al. Inborn errors of metabolism and motor disturbances in children. J Inherit Metab Dis 2009; 32: 618-29.
9. Gupta R, Appleton R. Cerebral palsy: not always what it seems. Arch Dis Child 2001; 85: 356-60.
10. Lee W-T, Weng W-C, Peng S-F, Tzen K-Y. Neuroimaging findings in children with paediatric neurotransmitter diseases. J Inherit Metab Dis 2009; 32: 361-70.
11. McFarland R, Chinnery PF, Blakely EL, et al. Homoplasmy, heteroplasmy, and mitochondrial dystonia. Neurology 2007; 69: 911-6.
12. Badawi N, Watson L, Petterson B, et al. What constitutes cerebral palsy? Dev Med Child Neurol 1998; 40: 520-7.
13. Parazzini C, Baldoli C, Scotti G, Triulzi F. Terminal zones of myelination: MR evaluation of children aged 20-40months. AJNR Am J Neuroradiol 2002; 23: 1669-73.
14. Yokochi K, Aiba K, Kodama M, Fujimoto S. Magnetic resonance imaging in athetotic cerebral palsied children. Acta Paediatr Scand 1991; 80: 818-23.
15. Esscher E, Flodmark O, Hagberg G, Hagberg B. Non-progressive ataxia: origins, brain pathology and impairments in 78 Swedish children. Dev Med Child Neurol 1996; 38: 285-96.
16. Miller G, Cala LA. Ataxic cerebral palsy - clinico-radiologic correlations. Neuropediatrics 1989; 20: 84-9.
17. Assmann B, Surtees R, Hoffmann GF. Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia. Ann Neurol 2003; 54(Suppl.): S18-24.
18. Blau N, Bonafé L, Krägeloh-Mann I, et al. Cerebrospinal fluid pterins and folates in Aicardi-Goutières syndrome: a new phenotype. Neurology 2003; 61: 642-7.
19. Dale RC, Brilot F, Fagan E, Earl J. Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation. Dev Med Child Neurol 2009; 51: 317-23.
20. Millner MM, Franthal W, Thalhammer GH, et al. Neopterin concentrations in cerebrospinal fluid and serum as an aid in differentiating central nervous system and peripheral infections in children. Clin Chem 1998; 44: 161-7.
21. Fink JK. Hereditary spastic paraplegia. Neurol Clin 2002; 20: 711-26.
22. Depienne C, Stevanin G, Brice A, Durr A. Hereditary spastic paraplegias: an update. Curr Opin Neurol 2007; 20: 674-80.